Since 2021 a healthcare transforming medicines company and subsidiary of ProBioGen AG and Minapharm Pharmaceuticals.
MiGenTra GmbH is a dynamic healthcare company focused on transforming medicines, operating as a subsidiary of ProBioGen AG and Minapharm Pharmaceuticals. Established in 2021, MiGenTra specializes in delivering high-quality medicines at affordable prices, contributing significantly to the biotechnology research sector.
Headquartered in Berlin, Germany, with access to a manufacturing site in Cairo, Egypt, MiGenTra is strategically positioned to develop products in Biosimilars, Cell and Gene Therapies, and vaccines. This allows MiGenTra to provide access to essential healthcare transforming medicines, particularly in Egypt, the Middle East, and Africa, while simultaneously enhancing regional and local manufacturing capabilities.
Located at Herbert-Bayer Straße 4, 13086 Berlin, DE, MiGenTra combines scientific and manufacturing expertise from both ProBioGen and Minapharm Pharmaceuticals. We invite the management of MiGenTra GmbH to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.
Other organizations in the same industry
This company is also known as